Oscar Health, Inc. (NYSE:OSCR) Position Raised by Deerfield Management Company L.P. Series C

Deerfield Management Company L.P. Series C increased its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 50.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 11,835,000 shares of the company's stock after buying an additional 3,983,325 shares during the period. Oscar Health comprises approximately 3.0% of Deerfield Management Company L.P. Series C's holdings, making the stock its 5th largest position. Deerfield Management Company L.P. Series C owned 4.79% of Oscar Health worth $159,062,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. JPMorgan Chase & Co. increased its holdings in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. BIT Capital GmbH raised its holdings in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Hennessy Advisors Inc. raised its holdings in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock worth $56,292,000 after acquiring an additional 3,544,300 shares in the last quarter. Gilder Gagnon Howe & Co. LLC boosted its position in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. Finally, Clearbridge Investments LLC purchased a new position in shares of Oscar Health in the fourth quarter valued at $19,088,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $20.08.

Oscar Health Trading Up 1.7%

Shares of OSCR stock traded up $0.29 during trading hours on Tuesday, reaching $17.11. 5,028,434 shares of the stock were exchanged, compared to its average volume of 5,085,163. The firm has a market capitalization of $4.29 billion, a price-to-earnings ratio of -855.07 and a beta of 1.75. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The company's 50-day moving average price is $13.35 and its 200-day moving average price is $14.62. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the business posted $0.62 earnings per share. The company's revenue for the quarter was up 42.2% on a year-over-year basis. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.